TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director. December 7, 2001
TCL Archive DCT Board Approves Major Clinical Trials Changes, Regional Groups, New Effort In Surgical Oncology October 10, 1980